Literature DB >> 17240001

Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases.

Ann W McMahon1, Rachel B Eidex, Anthony A Marfin, Michelle Russell, James J Sejvar, Lewis Markoff, Edward B Hayes, Robert T Chen, Robert Ball, M Miles Braun, Martin Cetron.   

Abstract

Yellow fever (YF), can be prevented by an attenuated vaccine (YEL). We reviewed neurologic adverse events (AE) following YEL that were reported to the national Vaccine Adverse Events Reporting System (VAERS). VAERS is a passive reporting system with inherent limitations for causality assessment. Based on defined criteria, five cases of encephalitis were classified as 'definitely' and one of acute disseminated encephalomyelitis (ADEM) as 'probably' caused by YEL. Six cases of Guillain-Barre Syndrome (GBS), one of encephalitis, and two of ADEM, were classified as 'suspect' vaccine-associated disease. Laboratory and epidemiological evidence suggests that YEL caused encephalitis. Additional studies will be required to confirm whether YEL can rarely result in GBS and/or ADEM.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17240001     DOI: 10.1016/j.vaccine.2006.11.027

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  30 in total

1.  Mapping the risk of yellow Fever infection.

Authors:  David R Hill
Journal:  Curr Infect Dis Rep       Date:  2012-06       Impact factor: 3.725

2.  NIAID workshop on Flavivirus immunity.

Authors:  Alison D Augustine; M Cristina Cassetti; Francis A Ennis; Eva Harris; William H Hildebrand; Patricia M Repik
Journal:  Viral Immunol       Date:  2010-06       Impact factor: 2.257

Review 3.  Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond.

Authors:  Veaceslav Boldescu; Mira A M Behnam; Nikos Vasilakis; Christian D Klein
Journal:  Nat Rev Drug Discov       Date:  2017-05-05       Impact factor: 84.694

4.  Transverse myelitis associated with yellow fever vaccination.

Authors:  Kyle D Bartol; Jose L Aguirre; Salvatore V Labruzzo; Russ P Henriet
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-03-26

5.  Yellow fever vaccine-associated neurological disease: it is not just the silver generation at risk.

Authors:  Emily J Goldstein; David J Bell; Rory N Gunson
Journal:  BMJ Case Rep       Date:  2019-05-13

6.  Repeated in vivo stimulation of T and B cell responses in old mice generates protective immunity against lethal West Nile virus encephalitis.

Authors:  Jennifer L Uhrlaub; James D Brien; Douglas G Widman; Peter W Mason; Janko Nikolich-Zugich
Journal:  J Immunol       Date:  2011-02-21       Impact factor: 5.422

7.  Clinical and immunological insights on severe, adverse neurotropic and viscerotropic disease following 17D yellow fever vaccination.

Authors:  Maria Luiza Silva; Luçandra Ramos Espírito-Santo; Marina Angela Martins; Denise Silveira-Lemos; Vanessa Peruhype-Magalhães; Ricardo Carvalho Caminha; Péricles de Andrade Maranhão-Filho; Maria Auxiliadora-Martins; Reinaldo de Menezes Martins; Ricardo Galler; Marcos da Silva Freire; Rugimar Marcovistz; Akira Homma; Dirk E Teuwen; Silvana Maria Elói-Santos; Mariléia Chaves Andrade; Andréa Teixeira-Carvalho; Olindo Assis Martins-Filho
Journal:  Clin Vaccine Immunol       Date:  2009-11-11

8.  A randomized, double-blind, controlled trial of the 17D yellow fever virus vaccine given in combination with immune globulin or placebo: comparative viremia and immunogenicity.

Authors:  Srilatha Edupuganti; Rachel B Eidex; Harry Keyserling; Rama S Akondy; Robert Lanciotti; Walter Orenstein; Carlos del Rio; Yi Pan; Troy Querec; Harvey Lipman; Alan Barrett; Rafi Ahmed; Dirk Teuwen; Martin Cetron; Mark J Mulligan
Journal:  Am J Trop Med Hyg       Date:  2012-12-03       Impact factor: 2.345

9.  Longitudinal myelitis associated with yellow fever vaccination.

Authors:  M Chaves; P Riccio; L Patrucco; J I Rojas; E Cristiano
Journal:  J Neurovirol       Date:  2009-07       Impact factor: 2.643

10.  Intrinsic Immunity Shapes Viral Resistance of Stem Cells.

Authors:  Xianfang Wu; Viet Loan Dao Thi; Yumin Huang; Eva Billerbeck; Debjani Saha; Hans-Heinrich Hoffmann; Yaomei Wang; Luis A Vale Silva; Stephanie Sarbanes; Tony Sun; Linda Andrus; Yingpu Yu; Corrine Quirk; Melody Li; Margaret R MacDonald; William M Schneider; Xiuli An; Brad R Rosenberg; Charles M Rice
Journal:  Cell       Date:  2017-12-14       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.